To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive suite of antibody discovery platforms.

The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...

A laser-based system that can create mesh-like structures in a dish that resemble the cytoskeletons of cells has been developed by two RIKEN researchers. They demonstrated its usefulness for research ...

Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, amoebic and viral pathogens presenting major diagnostic and therapeutic ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.